{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:33:49Z","timestamp":1778596429617,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"am","delay-in-days":263,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5T32 CA101642"],"award-info":[{"award-number":["5T32 CA101642"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["K07 CA201013"],"award-info":[{"award-number":["K07 CA201013"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP140020"],"award-info":[{"award-number":["RP140020"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160674"],"award-info":[{"award-number":["RP160674"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["SAC150061"],"award-info":[{"award-number":["SAC150061"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ygyno.2024.01.041","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T22:12:34Z","timestamp":1708380754000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Determination of quality of life-related health utilities for surgical complications in ovarian cancer"],"prefix":"10.1016","volume":"185","author":[{"given":"Rudy S.","family":"Suidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte C.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2024.01.041_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0b013e3182922a17","article-title":"Adherence to treatment guidelines for ovarian cancer as a measure of quality care","volume":"121","author":"Bristow","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0015","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study","volume":"25","author":"Winter","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2010.10.021","article-title":"EORTC 55971: does it apply to all patients with advanced state ovarian cancer?","volume":"120","author":"Rose","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S0266462300007121","article-title":"Economic analysis alongside clinical trials. Revisiting the methodological issues","volume":"7","author":"Drummond","year":"1991","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"10.1016\/j.ygyno.2024.01.041_bb0045","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00001813-199811000-00005","article-title":"Cost, quality of life and outcome measures in ovarian cancer","volume":"9","author":"Abbas","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2024.01.041_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ygyno.2012.10.024","article-title":"Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a gynecologic oncology group study","volume":"128","author":"Hess","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2008.12.026","article-title":"Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment","volume":"113","author":"Havrilesky","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2004.01.017","article-title":"A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians","volume":"93","author":"Calhoun","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0070","first-page":"1727","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehab."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/02729890122062622","article-title":"Visual analog scales: do they have a role in the measurement of preferences for health states?","volume":"21","author":"Torrance","year":"2001","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/gyno.2002.6807","article-title":"Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?","volume":"87","author":"Sun","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0085","series-title":"CHEPA Working Paper Series No. 95\u20137","article-title":"Moran LA at the Centre for Health Economics and Policy Analysis. A practical guide to health-state preference measurement: A video introduction","author":"O\u2019Brien","year":"1995"},{"key":"10.1016\/j.ygyno.2024.01.041_bb0090","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology statement: a conceptual framework to assess the value of Cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.041_bb0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/diagnostics12040988","article-title":"Surgery in advanced ovary cancer: primary versus interval cytoreduction","volume":"12","author":"Cummings","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00520-004-0710-6","article-title":"Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer","volume":"13","author":"Sun","year":"2005","journal-title":"Support. Care Cancer Off. J. Multinat. Assoc. Supporti. Care Cancer."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0105","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/IGC.0b013e318299e2a6","article-title":"Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers","volume":"23","author":"Jewell","year":"2013","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s11605-018-3671-7","article-title":"Health state utility values for ileostomies and colostomies: a systematic review and meta-analysis","volume":"22","author":"Dossa","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.1998.5189","article-title":"Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists","volume":"71","author":"Calhoun","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0120","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ehrm.2010.02.001","article-title":"Preferences of patients and oncologists for advanced ovarian cancer treatment-related health states","volume":"1","author":"Hess","year":"2010","journal-title":"Health Outcomes Res. Med."},{"key":"10.1016\/j.ygyno.2024.01.041_bb0125","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0016-5085(91)90081-U","article-title":"Quality of life of patients with ulcerative colitis preoperatively and postoperatively","volume":"101","author":"McLeod","year":"1991","journal-title":"Gastroenterology."},{"issue":"50","key":"10.1016\/j.ygyno.2024.01.041_bb0130","article-title":"Health state utility and health-related quality of life measures in patients with advanced ovarian cancer","author":"van Stein","year":"2023","journal-title":"Gynecol. Oncol. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:35:05Z","timestamp":1732610105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":26,"alternative-id":["S0090825824000672"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.041","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of quality of life-related health utilities for surgical complications in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}